TERRAY THERAPEUTICS
12.17.2024
Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact
FIERCE BIOTECH >
REJUVENATE BIO
12.11.2024
Protect Animal Health and Rejuvenate Bio Partner to Tackle Canine Heart Disease
GENE ONLINE >
NUVIG THERAPEUTICS
12.5.2024
Sanofi-backed Nuvig marches lead autoimmune therapy into phase 2 with $161M series B
FIERCE BIOTECH >
SWITCH THERAPEUTICS
12.4.2024
Switch Therapeutics nominates liver-sparing APOE RNAi therapy as development candidate for Alzheimer’s
BIOWORLD >
ELEMENTAL MACHINES
12.4.2024
Elemental Machines Debuts a New Solution for Clean Room Monitoring
TREND HUNTER >
TERRAY THERAPEUTICS
12.3.2024
Using AI to design small molecule drugs is tough. Here are five companies trying to crack the code
STAT >
FAETH THERAPEUTICS
11.22.2024
Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors
business wire >
ELEMENTAL MACHINES
11.21.2024
Elemental Machines Launches New Product to Enhance Clean Room Alerting and Monitoring
YAHOO! FINANCE >
ASCEND
11.12.2024
Ascend Advanced Therapies Partners with EW Healthcare Partners to Expand United States Capacity and Capabilities
PR NEWSWIRE >
TERRAY THERAPUETICS
11.12.2024
BioSpace Announces 2025 Best Places to Work in Biopharma
BIOSPACE >
ONC.AI
11.6.2024
Onc.AI Serial Imaging Response Score Outperforms Traditional Methods for Early Assessment of NSCLC Immunotherapy Outcomes
BIOSPACE >
SWITCH THERAPEUTICS & JUDO BIO
11.6.2024
An RNAi renaissance is creating a new generation of startups
YAHOO! FINANCE >
POSITIVE DEVELOPMENT
11.4.2024
New Autism Therapy Models Gain Traction as Industry Diversifies
BEHAVIORAL HEALH BUSINESS >
EPIBIOLOGICS
11.4.2024
EpiBiologics to Present Data Demonstrating Disease-Selective Extracellular Protein Degradation and Platform Breadth at Upcoming Scientific Meetings
YAHOO! FINANCE >
ALTEROME THERAPEUTICS
10.30.2024
Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001)
BUSINESS WIRE >
FINDHELP
10.30.2024
Findhelp and LBJ School of Public Affairs Announce Post-Election Video Podcast on Fixing the Social Safety Net
YAHOO! FINANCE >
EXPRESSABLE
10.30.2024
Expressable Speech Therapy Awarded Accreditation from The Joint Commission
PR NEWSWIRE >
TERRAY THERAPEUTICS
10.28.2024
Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
BUSINESS WIRE >
JUDO BIO
10.28.2024
Judo Bio Presents Data Demonstrating Mechanism of Receptor-mediated Delivery of Oligonucleotides Resulting in Gene Silencing in the Kidney
YAHOO! FINANCE >
ALTEROME THERAPEUTICS
10.25.2024
Alterome Therapeutics to Present Preclinical Data for its KRAS Selective Inhibitor ALTA3263 at the 2024 ENA Symposium
YAHOO! FINANCE >
ONC.AI
10.24.2024
Onc.AI Awarded $2 Million National Cancer Institute Grant to Advance AI-based Clinical Decision Support for Metastatic NSCLC
BIOSPACE >
Alpha-9 Oncology
10.23.2024
Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals
CNHI NEWS >
TERRAY THERAPEUTICS
10.21.2024
Terray Therapeutics aims for the clinic by 2026
C&EN >
TERRAY THERAPEUTICS
10.17.2024
Terray raises $120M for its AI ways of designing molecules
ENDPOINTS NEWS >
TERRAY THERAPEUTICS
10.17.2024
Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic
STREET INSIDER >
Alterome Therapeutics
10.17.2024
Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to Goldman Sachs Top 100 Most Exceptional Entrepreneurs at 2024 Builders and Innovators Summit
BUSINESS WIRE >
SWITCH THERAPEUTICS
10.14.2024
Editor's Pick: Switch Therapeutics
NATURE BIOTECHNOLOGY >
REEMA HEALTH
10.10.2024
Reema Health raises $7.6M to reach people on Medicaid
ENDPOINT NEWS >
JUDO BIO
10.7.2024
Judo Bio Launches with $100 Million Financing to Develop Oligonucleotide Therapies
BUSINESS WIRE >
CARDURION PHARMACEUTICALS
9.26.2024
Endpoints 11 winner Cardurion Pharmaceuticals: A shot at one of heart disease’s 'undruggable' targets
ENDPOINTS NEWS >
NATIVE PET
9.12.2024
7 Best Probiotics for Dogs and Their Digestive Health 2024
U.S. NEWS & WORLD REPORT >
SCRATCHPAY
8.15.2024
Scratch Financial is a 2024 Inc. 5000 honoree
INC. >
GALATEA BIO
8.14.2024
DNAnexus, Galatea Bio Collaborate to Improve Access to Genetic Tools in Underserved Populations
GENOME WEB >
eLEMENTAL MACHINES
8.13.2024
Sridhar Iyengar, founder of Elemental Machines, writes on critical improvements to lab safety, compliance, and efficiency
LAB MANAGER >
EXPRESSABLE
7.31.2024
WellCare of North Carolina and Expressable Expand Advanced Speech Therapy Program Across the State
LONGVIEW NEWS-JOURNAL >
GRO BIOSCIENCES
7.19.2024
GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology
BUSINESS WIRE >
FAETH THERAPEUTICS
7.17.2024
Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase
YAHOO FINANCE >
DIGITALIS VENTURES
7.16.2024
The Intersection of Science & Startup Entrepreneurship w/ Dr. Misti Ushio
Burkland >
CARDURION PHARMACEUTICALS
7.16.2024
Heart disease biotech Cardurion lands $260M to advance PDE9 and CaMKII drugs
FIRST WORD PHARMA >
SEQURE DX
7.16.2024
New licensing agreement between Integrated DNA Technologies, SeQure Dx, will advance CRISPR-based therapeutics
CORRIDOR BUSINESS JOURNAL >
POSITIVE DEVELOPMENT
7.10.2024
Positive Development Expands Leadership Team with Hiring of New Chief Clinical Officer and Chief Financial Officer
MORNINGSTAR >
REJUVENATE BIO
7.1.2024
Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)
BUSINESS WIRE >
ELEMENTAL MACHINES
6.27.2024
Elemental Machines Expands European Presence and Enhances AI-Predicted Health Score
MORNINGSTAR >
Positive Development
6.20.2024
Positive Development Announces Substantial Investment by Healthworx to Support Neurodivergent Members
Business Wire >
TERRAY THERAPEUTICS
6.17.2024
How A.I. Is Revolutionizing Drug Development
THE NEW YORK TIMES >
T-Therapeutics
6.12.2024
T-Therapeutics appoints Dr David Hung as Chairman
YAHOO! FINANCE >
CAYABA CARE
6.3.2024
How Cayaba Care is Transforming Maternal Health
ibx insight >
Faeth Therapeutics
5.30.2024
Faeth Therapeutics to Participate in Upcoming Jefferies Investor Conference
YAHOO! FINANCE >
ONC.AI
5.30.2024
Onc.AI to Present Collaboration Results Demonstrating Immunotherapy Response Prediction
BAKERSFIELD >
EXPRESSABLE
5.23.2024
Expressable brings speech therapy into the home
TECHCRUNCH >
CAYABA CARE
5.7.2024
Cayaba Care is aiming to improve 'abysmal' maternal health outcomes in Philly and beyond
THE PHILADELPHA INQUIRER >
BONUM THERAPEUTICS
4.29.2024
Bonum Therapeutics to Present on its Novel Platform for Generating Conditionally Activated Targeted Therapies at Keystone Conference
BUSINESS WIRE >
TERRAY THERAPEUTICS
4.25.2024
The Difference Is the Data: Drug Discovery’s AI Revolution
GENETIC ENGINEERING & BIOTECH NEWS >
FINDHELP
4.4.2024
Findhelp Partners with State of Missouri to Support Families with Young Children
PR Newswire >
CAYABA CARE
4.2.2024
Cayaba Care Welcomes Adaeze Enekwechi As New CEO
KXAN News >
GALATEA BIO
3.14.2024
A biobank for the Americas and a genomics lab power precision health for all
ILLUMINA >
Nuvig Therapeutics
2.12.2024
Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089
BioSpace >
Terray Therapeutics
2.5.2024
New publication: COATI: Multimodal Contrastive Pretraining for Representing and Traversing Chemical Space
Journal of Chemical Information and Modeling >
Elegen
1.31.2024
Elegen Partners with GSK
Synbio Beta >
Ansel
1.23.2024
Ansel Raises $20M to Ensure Employees are Fully Covered with Supplemental Insurance
ALLEY WATCH
Bonum
1.3.2024
Bonum was named as one of the “Top Bioscience Companies to Watch” by Biospace
BioSpace >
Terray Therapeutics
12.14.2023
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
PR Newswire >
T-Therapeutics
11.15.2023
Sanofi-backed T-Therapeutics bags $59M in Series A to unlock potential of TCR therapeutics
Endpoints News >
Code Ocean
11.9.2023
Code Ocean Honored by the 2023 BioTech Breakthrough Awards
PR Web >
Faeth Therapeutics
11.8.2023
Faeth Therapeutics to Participate in the Stifel 2023 Healthcare Conference
Business Wire >
Findhelp
11.2.2023
Findhelp to Partner with Delaware to Build Search and Referral System for Substance Abuse and Mental Health Treatment
PR NewsWire >
DIGITALIS VENTURES
10.25.2023
Mars Companion Fund to take bigger bets on petcare startups
GLOBAL CORPORATE VENTURING >
Native Pet
10.16.2023
Native Pet launches new all-in-one supplement
Pet Food Processing >
Faeth Therapeutics
10.13.2023
Faeth Therapeutics Announces National Academy of Medicine Recognition for Co-founder Dr. Siddhartha Mukherjee
Business Wire >
Eden Brew
10.11.2023
Eden Brew alternative milk startup attracts $25m in investments to bring synthetic dairy to market
ABC News >
Rejuvenate Bio
10.9.2023
Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy
BioSpace >
Nuvig Therapeutics
10.4.2023
Nuvig Therapeutics Appoints Dr. Alan Glicklich Chief Medical Officer
Business Wire >
DIGITALIS VENTURES
10.3.2023
Mars and Digitalis Ventures launch $300m Fund to improve the lives of pets…
MARS >
Terray Therapeutics
10.2023
A New Molecular Language for Generative AI in Small-Molecule Drug Discovery
NVIDIA >
GRO Biosciences
9.27.2023
GRO Biosciences Presents Preclinical Data on Two ProGly™ Programs for Non-Standard Amino Acid Therapies
Business Wire >
Positive Development
8.30.2023
The AMA supports Developmental Services with the passing of AMA Resolution 706
BUSINESS WIRE >
Native Pet
8.10.2023
Native Pet continues to reinforce commitment to pet health, announces $11 million in Series B funding
PR Newswire >
EpiBiologics
8.3.2023
EpiBiologics: Protein Degradation Platform Company Closes Over $70 Million
Pulse 2.0 >
DIGITALIS COMMONS
7.25.2023
Digitalis Commons Secures First Commercialization Agreement For ARPA-H's Project Accelerator
PR NEWSWIRE >
Elemental Machines
7.20.2023
Elemental Machines Announces Edward Seguine As New Chief Executive Officer
PR Newswire >
GRO Biosciences
7.13.2023
GRO Biosciences demonstrates how automated technologies enable its scientists to test wide spaces
Biotech TV >
Somatix
7.11.2023
Somatix and Roche Launch an Only-of-Its-Kind Medication Compliance Capability Using AI-Enabled Wearable Technology
Access Wire >
Terray Therapeutics,
GRO Biosciences,
Faeth Therapeutics
7.5.2023
The Next Generation of Bio Companies
Decoding Bio >
Cabaya Care
5.12.2023
Cayaba Care and Axia Women’s Health Initiate Partnership to Address Maternal Health Equity
Business Wire >
Code Ocean
4.25.2023
Code Ocean Accelerates Pharmaceutical and Biotech Research
PR News Wire >
GRO Biosciences
4.11.2023
GRO Biosciences CEO, Daniel J. Mandell, PhD, Awarded 2023 Termeer Fellowship
Business Wire >
Switch Therapeutics
3.14.2023
Switch Therapeutics Raises $52M in Series A Funding
FINSMES >
Code Ocean
2.17.2023
Code Ocean Partners with Nature Portfolio to Launch the Open Science Library with Ready-to-Run Software from Authors in Nature Journals
PR Newswire >
Terray Therapeutics
2.13.2023
Paths to cheminformatics: Q&A with Phyo Phyo Kyaw Zin
Journal of Cheminformatics >
Scratchpay
1.31.2023
Scratch and Wellfit Partner to Deliver Access to Flexible Payment Options to Dental Patients Across the Country
PR Newswire >
Native Pet
1.25.2023
Dog Is Our Native Tongue: Native Pet Unveils New Branding and Commitments to the Pet Nutrition Industry
PR Newswire >
Rejuvenate Bio
1.9.2023
Rejuvenate Bio Announces New Preclinical Research Evaluating Cellular Reprogramming for Age Reversal
Business WirE >
ANSEL
1.7.2023
Brella Insurance rebrands to Ansel
COVERAGER >
Onc.ai
1.5.2023
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
Business Wire >
Nuvig Therapeutics
1.4.2023
Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer
Business Wire >
Elemental Machines
12.18.2022
Elemental Machines Is Bringing The Internet Of Things To Lab Operations To Save Millions Of Dollars For Biotech Companies
Forbes >
Terray Therapeutics
12.13.2022
Terray Therapeutics Appoints John Maraganore, Ph.D., as Strategic Advisor
Bezinga >
GRO Biosciences
12.1.2022
Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell
Finding Genius Podcast >
Terray Therapeutics
11.30.2022
Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director
PRNewswire >
Faeth Therapeutics
11.23.2022
A recipe for cancer, new clinical trial comes to Birmingham
CBS42 >
Bonum Therapeutics
11.15.2022
The team that sold its lead IL-2 program to Roche is back with $93M to work on more next-gen I/O drugs
Endpoints >
MySimplePetLab
11.10.2022
MySimplePetLab Raises Series A Funding
Finsmes >
Elemental Machines
11.10.2022
Elemental Machines raises $41 million to fuel growth
PRNewswire >
Matchpoint Therapeutics
10.14.2022
Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent Medicines for Immune Diseases
BusinessWire >
findhelp
10.13.2022
PointClickCare Announces Partnership with findhelp to Improve Social Determinants of Health Care Outcomes for Vulnerable Populations
BusinessWire >
Terray Therapeutics
10.12.2022
Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico
EndPoints >
Faeth Therapeutics
10.6.2022
Precision nutrition is the fourth pillar in cancer care, says Faeth Therapeutics
Vitafoods Insight >
Faeth Therapeutics
10.6.2022
‘Food-as-Medicine’ Startups Draw Venture Capital
WSJ
Terray Therapeutics
10.4.2022
AI Is Making Its Way Into Drug Discovery. What Does It Mean For Biotech?
CrunchBase >
Galatea
10.2022
Future of Precision Health w/ Carlos Bustamante - Professor @ Stanford / Co-Founder & CEO @ Galatea - BIOS
SPOTIFY >
Scratchpay
9.20.2022
Healthcare financier Scratchpay secures $35M Series C
TechCrunch >
Faeth Therapeutics
9.11.2022
Faeth Therapeutics offers food for thought in the fight against cancer
The Times >
Kingdom Superculture
9.6.2022
How Microbial Fermentation Is Taking Eleven Madison Park’s Vegan Menu to the Next Level
VegNews >
Code Ocean
7.19.2022
Code Ocean Announces Open Science Library Allowing No-cost, Turn-key Replication of Computational Science Experiments
PR Newswire >
Elemental Machines
7.19.2022
Elemental Machines Introduces Lab-Wide Equipment Usage Intel Solution
lab manager >
Terray Therapeutics
7.12.2022
Terray Therapeutics Expands Scientific Advisory Board to Advance AI-Driven Small Molecule Drug Discovery
PR Newswire >
Rejuvenate Bio
7.11.2022
Gene therapy may soon help treat mitral valve disease
avma.org >
Faeth Therapeutics
6.30.2022
Faeth Therapeutics raises $47 million to advance clinical trials and feed the fight against cancer
PR NewsWire >
Faeth Therapeutics
6.29.2022
Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions
Endpoints News >
Elemental Machines
6.24.2022
MasterControl and Elemental Machines Form Biomanufacturing Partnership
Contract PharmA >
Digitalis Portfolio Companies Are Hiring
See All Open Positions